BSECompany Update12 Sept 2026 · 12 Sept 2026, 04:16 pm
1. Redesignation of shri Balram Viswanathan (DIN :10245195)as Chairman and Managing Director of the company. 2.Appointment of Dr Smt Neeti Kapre (DIN:06801264)as Non Executive Independent Director
Sandu Pharmaceuticals Ltd · 524703
✦ AI SummaryMgmt Change
Sandu Pharmaceuticals Ltd has announced the redesignation of Balram Viswanathan as Chairman and Managing Director for 3 years and the appointment of Neeti Kapre as Non-Executive Independent Director for 5 years, both effective from July 11, 2026.
Analysis Scores
Earnings Impact2/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Sandu Pharmaceuticals Ltd - 524703 - Announcement under Regulation 30 (LODR)-Change in Directorate
Attachments (1)
📄pdf
Download →
38b38a7b-085a-402b-974f-7b5ca379e15b.pdf
View document text
£- SANDU PHARMACEUTICALS LIMITED
CIN:L24233GA1985PLC001587
SAMD‘U
w Regd. Office: Plot Nos. 25, 26, 29 & 30, Pilerne Industrial Estate, Marra, Saligao, Bardez, Goa 403511.
Tel: +91 832 2407474 / 6715000, E-mail: sandupharma@sandu.in, Website: www.sandu.in
Ref No: Corp.Sec/BSE/2026-27/488
Dated:12.09.2026
Bombay Stock Exchange Ltd,
Phirojshah Jeejobhoy Towers,
25" Floor, Dalal Street,
Mumbai 400 001
Manager-Department of Corporate affairs
Dear Sir,
Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosures
Requirements) Regulations, 2015
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, we wish to inform you that the Members of Sandu Pharmaceuticals Limited, at
the 41st Annual General Meeting of the Company held on Friday, September 11, 2026, through
Video Conferencing/Other Audio-Visual Means, have approved the following appointments:
1. Redesignation of Shri Balram Viswanathan (DIN: 10245195) as Chairman and Managing
Director of the Company for the term of 03 years .
2. Appointment of Ms. Neeti Kapre (DIN:06801264) -as Non-Executive Independent
Director of the Company for the term of 05 years
The aforesaid appointments were approved by the Members by passing the requisite resolutions as
set out in the Notice convening the 41st Annual General Meeting.
The details of the appointments, as required under Regulation 30 read with Schedule III of the
SEBI LODR Regulations, 2015, are enclosed as Annexure A & B
Kindly take this intimation in record in compliance with applicable statutory provisions.
Kindly take above intimation in your record
Thanking You
Yours Faithfully,
AN ISO 9001:2015 CERTIFIED ORGANISATION <>
Cnrporale Office: P. B. No. 17201, Sandu ngdr, D. K. Sandu Marg, Chembur, Mumbai — 400 071 /
Tel.: +91 22 2528 4402 / 3306, E-mail: info@sandu.in
oN ors! 0
4% __ SANDU PHARMACEUTICALS LIMITED
CIN:L24233GA1985PLC001587
SAMD‘U
w Regd. Office: Plot Nos. 25, 26, 29 & 30, Pilerne Industrial Estate, Marra, Saligao, Bardez, Goa 403511.
Tel: +91 832 2407/ 4677154000 , E-mail: sandupharma@sandu.in, Website: www.sandu.in
FOR SANDU PHARMACEUTICALS LIMITED
PRATIKA MHAMBRAY
COMPANY SECRETARY & COMPLIANCE OFFICER
A36512
AN I1SO 9001:2015 CERTIFIED ORGANISATION
Corporate Office: P. B. No. 17201, Sandu Nagar, D. K. Sandu Marg, Chembur, Mumbai — 400 071
Tel.: +91 22 2528 4402 / 3306, E-mail: info@sandu.in
- SANDU PHARMACEUTICALS LIMITED
SA.:F/DU
CIN:L24233GA1985PLC001587
Regd. Office: Plot Nos. 25, 26, 29 & 30, Pilerne Industrial Estate, Marra, Saligao, Bardez, Goa 403511.
Tel: +91 832 2407474 / 6715000, E-mail: sandupharma@sandu.in, Website: www.sandu.in
Annexure A
Disclosure of information pursuant to Regulation 30 of SEBI (Listing Obligations and _Disclosure
Requirements) Regulations, 2015 read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-
POD2/1/3762/2026 dated 30th January 2026
Sr No Particulars Details
1 Name of the Director/ Key Shri Balram Viswanathan (DIN: 10245195)
Managerial Personnel
2 Reason for change Redesignation from Chairman and Non-Executive
Independent Director to Chairman and Managing
Director
3 Date of appointment With effect from 11t July 2026
/Cess&a ttierom n—o f
appointment
Term of appointment: Shri Balram Viswanathan
(DIN: 10245195) is appointed as Chairman and
Managing Director for the term of 03 years with
effect from 11t July 2026
4 Brief Profile Shri. Balram Viswanathan is a B.Com., FCA and CPA
(USA) with over 30 years of rich and diverse experience
in the financial services industry. An Ex-Banker, his areas
of expertise include Audit, Taxation, Mergers &
Acqui ns Advisory, Due Diligence, Compliance,
Valuation Services, Financial Control, Financial Planning
& Analysis, Regulatory Reporting, Business Strategy,
Treasury and Risk Management.
5 Disclosure of relationships Shri. Balram Viswanathan is not related to any
between directors (in case of Director and/or Key Managerial Personnel
appointment of a director) and/or Promoters of the Company.
6 Information as required Shri. Balram Viswanathan Not debarred from
Circular No. LIST/COMP/ | holding the office of a director by virtue of any
14/2018- 19 and order passed by SEBI
NSE/CML/2018/24
AN ISO 9001:2015 CERTIFIED ORGANISATION
Corporate Office: P. B. No. 17201, Sandu Nagar, D. K. Sandu Marg, Chembur, Mumbai — 400 071 {
Tel.: 9122 2528 4402 / 3306, E-mail: info@sandu.in |
SANDU PHARMACEUTICALS LIMITED
SA.:F?DU
CIN:L24233GA1985PLC001587
Regd. Office: Plot Nos. 25, 26, 29 & 30, Pilerne Industrial Estate, Marra, Saligao, Bardez, Goa 403511.
Tel: +91 832 2407474 / 6715000, E-mail: sandupharma@sandu.in, Website: www.sandu.in
ANNEXURE B
Disclosure of information pursuant to Regulation 30 of SEBI (Listing Obligations and _Disclosure
Requirements) Regulations, 2015 read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-
POD2/1/3762/2026 dated 30th January 2026
Sr Particulars Details
1 Name of the Director/ Dr Neeti Madan Kapre (DIN:06801264)
KeyManagerial Personnel
2 Reason for change Appointed as Non-Executive Independent Director
3 Date of appointment With effect from 11t July 2026
|/ Cessat& iteormn o f
appointment
Term of appointment: - Appointment of Dr Neeti
Madan Kapre (DIN:06801264) as Non-Executive
Independent Director for a term of five (5) years
effective 11t July 2026 ,not liable to retire by
rotation.
4 Brief Profile Dr Neeti Madan Kapre has done
e MBBS- Gold Medallist (First class with Distinction all 4
years)- Indira Gandhi Government Medical College,
Nagpur
e M.S (ENT) — K.E.M. Hospital, Mumbai
e D.N.B(ENT)
e Clinical Research Fellow, Head and Neck Services,
TMH, Mumbai (August 2013 to August 2015)
e Global Fellowship Programme, International
Foundation Head and Neck Oncologic Societies
e Observer ship under the Global Fellowship Programme
at Memorial Sloan Kettering Cancer Centre, New York
Memberships
e Founder Member —
(a)Indian Society of Thyroid Surgeons
(b)Vidarbha Society of Head and Neck Oncology
* Executive committee member-
AN ISO 9001:2015 CERTIFIED ORGANISATION <>
Corporate Office: P. B. No. 17201, Sandu Nagar, D. K. Sandu Marg, Chembur, Mumbai ~ 400 071 7
91 22 2528 4402 / 3306, E-mail: info@sandu.in H
Tel.:
4% __ SANDU PHARMACEUTICALS LIMITED
CIN:L24233GA1985PLC001587
SAMDU
w Regd. Office: Plot Nos. 25, 26, 29 & 30, Pilerne Industrial Estate, Marra, Saligao, Bardez, Goa 403511.
Tel: +91 832 2407474 / 6715000, E-mail: sandupharma@sandu.in, Website: www.sandu.in
Indian Society of Thyroid Surgeons
Thyroid Society Nagpur
e Life Member - Asia Pacific Thyroid Society
- Foundation of Head & Neck Oncology
- Association of Otolaryngologist in
India
- Vidarbha Society of Head & Neck
Oncology
- Indian Society of Otolaryngologist.
5 Disclosure of Dr Neeti Madan Kapre is not related to any Director
relationships between and/or Key Managerial Personnel and/or Promoters of
directors (in case of the Company.
appointment of a
director)
6 Information as required Dr Neeti Madan Kapre Not debarred from holding the
Circular No. LIST/COMP/ office of a director by virtue of any order passed by
14/2018- 19 and SEBI
NSE/CML/2018/24
FOR SANDU PHARMACEUTICALS LIMITED
PRATIKA MHAMBRAY
COMPANY SECRETARY & COMPLIANCE OFFICER
A36512
AN ISO 9001:2015 CERTIFIED ORGANISATION
Corporate Office: P. B. No. 17201, Sandu Nagar, D. K. Sandu Marg, Chembur, Mumbai — 400 071
91 22 2528 4402 / 3306, E-mail: info@sandu.in